Viemed Healthcare Inc

Viemed Healthcare Inc (VMD) Stock Analysis

$9.920

+0.173 (+1.74%)At close

Loading chart…
High
9.950
Open
9.760
VWAP
9.84
Volume
147.00K
Mkt Cap
251.17M
Low
9.650
Amount
1.45M
EV/EBITDA, TTM
7.00

Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services.

AI analysis of Viemed Healthcare Inc (VMD)

Hold

Viemed Healthcare Inc (VMD) is currently a hold. The stock is priced at $9.48, with a forward P/E of 18.35, indicating potential for growth, but recent earnings missed expectations with an EPS of $0.07 compared to the estimate of $0.10. The company has shown strong revenue growth, with a 31.3% year-to-date change, but the recent downgrade by Freedom Broker suggests caution due to near-term profitability pressures.

Valuation Metrics

The current forward P/E ratio for Viemed Healthcare Inc (VMD) is 18.35, compared to its 5-year average forward P/E of 23.93.

Forward P/E

Fair
5Y Average P/E
23.93
Current P/E
18.35
Overvalued
30.94
Undervalued
16.91

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
6.05
Current EV/EBITDA
7.00
Overvalued
7.37
Undervalued
4.72

Forward P/S

Fair
5Y Average P/S
1.31
Current P/S
1.05
Overvalued
1.65
Undervalued
0.98

Alphio AI Price Scenarios for VMD

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%VMD

$9.49

Scenario price

B

Base

Base · 50%VMD

$8.88

Scenario price

B

Bear

Bear · 25%VMD

$7.16

Scenario price

Events Timeline

2026-03-04 (ET)

16:50:00

Viemed Healthcare Authorizes Share Repurchase Program Through March 2027

2025-07-02 (ET)

08:43:56

Viemed Healthcare completes acquisition of Lehan's Medical Equipment

2025-06-09 (ET)

08:18:09

Viemed Healthcare board authorizes share repurchase program up to 5%

2025-05-06 (ET)

08:32:47

Viemed entered into definitive agreement to acquire Lehan's Medical Equipment

2025-03-10 (ET)

17:02:06

Viemed Healthcare sees FY25 revenue $254M-$265M, consensus $251.43M

News

VMD FAQ — answered by Alphio AI

Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services. It operates in the Healthcare sector (SERVICES-MISC HEALTH & ALLIED SERVICES, NEC industry).

Viemed Healthcare Inc (VMD) is currently a hold. The stock is priced at $9.48, with a forward P/E of 18.35, indicating potential for growth, but recent earnings missed expectations with an EPS of $0.07 compared to the estimate of $0.10. The company has shown strong revenue growth, with a 31.3% year-to-date change, but the recent downgrade by Freedom Broker suggests caution due to near-term profitability pressures.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading